Shares of Clovis Oncology (CLVS) are trading higher on Friday after the company reported financial results from the fourth quarter of 2013 and discussed the development of its pipeline after
It’s been a big year for biotech. Heck, it’s been a big year for most of the health care sector, but biotech’s been among the biggest gainers across the entire market, with the
Shares for Clovis Oncology (CLVS) are currently in their second straight day of over 10 percent gains. Last Friday, the company’s stock gained 15.6 percent to close at $21.81, and Monday saw
